We tested an unselected and rather large cohort of early breast cancer patients, thus we assume that our data provide a realistic view, demonstrating a lack of a general impact of PIK3CA-mutations on the course of disease in breast cancer. This evidence concerns the gene PIK3CA and breast cancer.